NuPeak Therapeutics, Inc.
A first-in-kind drug for asthma and COPD
St. Louis, United States · Founded 2018
- Headquarters
- St. Louis, Missouri
- Employees
- 1–10
- Founded
- 2018
- Business Model
- B2B
- Website
- nupeak-therapeutics.com
About
NuPeak Therapeutics is a drug discovery and development biotech focused on small-molecule kinase inhibitors that correct epithelial stem cell and innate immune cell reprogramming. Their lead compound NuP-4B targets post-viral airway inflammation and mucus production in asthma and COPD, with inhaled delivery and disease-modifying mechanisms not found in current therapies. The company also pursues applications in breast, liver, and brain cancers.
Summary
NuPeak Therapeutics, Inc. is a Biotech company based in St. Louis, United States, founded in 2018.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/nupeak-therapeutics-inc"><img src="https://indexed.vc/api/badge/company/nupeak-therapeutics-inc" alt="NuPeak Therapeutics, Inc. on Indexed.vc" width="260" height="76" /></a>